These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25721401)

  • 1. Complex I assembly function and fatty acid oxidation enzyme activity of ACAD9 both contribute to disease severity in ACAD9 deficiency.
    Schiff M; Haberberger B; Xia C; Mohsen AW; Goetzman ES; Wang Y; Uppala R; Zhang Y; Karunanidhi A; Prabhu D; Alharbi H; Prochownik EV; Haack T; Häberle J; Munnich A; Rötig A; Taylor RW; Nicholls RD; Kim JJ; Prokisch H; Vockley J
    Hum Mol Genet; 2015 Jun; 24(11):3238-47. PubMed ID: 25721401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACAD9, a complex I assembly factor with a moonlighting function in fatty acid oxidation deficiencies.
    Nouws J; Te Brinke H; Nijtmans LG; Houten SM
    Hum Mol Genet; 2014 Mar; 23(5):1311-9. PubMed ID: 24158852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal multiorgan failure due to ACAD9 mutation and complex I deficiency with mitochondrial hyperplasia in liver, cardiac myocytes, skeletal muscle, and renal tubules.
    Leslie N; Wang X; Peng Y; Valencia CA; Khuchua Z; Hata J; Witte D; Huang T; Bove KE
    Hum Pathol; 2016 Mar; 49():27-32. PubMed ID: 26826406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acyl-CoA dehydrogenase 9 is required for the biogenesis of oxidative phosphorylation complex I.
    Nouws J; Nijtmans L; Houten SM; van den Brand M; Huynen M; Venselaar H; Hoefs S; Gloerich J; Kronick J; Hutchin T; Willems P; Rodenburg R; Wanders R; van den Heuvel L; Smeitink J; Vogel RO
    Cell Metab; 2010 Sep; 12(3):283-94. PubMed ID: 20816094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of mitochondrial bioenergetics, dynamics, endoplasmic reticulum-mitochondria crosstalk, and reactive oxygen species in fibroblasts from patients with complex I deficiency.
    Leipnitz G; Mohsen AW; Karunanidhi A; Seminotti B; Roginskaya VY; Markantone DM; Grings M; Mihalik SJ; Wipf P; Van Houten B; Vockley J
    Sci Rep; 2018 Jan; 8(1):1165. PubMed ID: 29348607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe defect in mitochondrial complex I assembly with mitochondrial DNA deletions in ACAD9-deficient mild myopathy.
    Fragaki K; Chaussenot A; Boutron A; Bannwarth S; Cochaud C; Richelme C; Sacconi S; Paquis-Flucklinger V
    Muscle Nerve; 2017 Jun; 55(6):919-922. PubMed ID: 27438479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new genetic disorder in mitochondrial fatty acid beta-oxidation: ACAD9 deficiency.
    He M; Rutledge SL; Kelly DR; Palmer CA; Murdoch G; Majumder N; Nicholls RD; Pei Z; Watkins PA; Vockley J
    Am J Hum Genet; 2007 Jul; 81(1):87-103. PubMed ID: 17564966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lifetime exercise intolerance with lactic acidosis as key manifestation of novel compound heterozygous ACAD9 mutations causing complex I deficiency.
    Schrank B; Schoser B; Klopstock T; Schneiderat P; Horvath R; Abicht A; Holinski-Feder E; Augustis S
    Neuromuscul Disord; 2017 May; 27(5):473-476. PubMed ID: 28279569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and characterization of a mouse model for Acad9 deficiency.
    Sinsheimer A; Mohsen AW; Bloom K; Karunanidhi A; Bharathi S; Wu YL; Schiff M; Wang Y; Goetzman ES; Ghaloul-Gonzalez L; Vockley J
    Mol Genet Metab; 2021; 134(1-2):156-163. PubMed ID: 34556413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assembly defects of multiple respiratory chain complexes in a child with cardiac hypertrophy associated with a novel ACAD9 mutation.
    Fragaki K; Chaussenot A; Boutron A; Bannwarth S; Rouzier C; Chabrol B; Paquis-Flucklinger V
    Mol Genet Metab; 2017 Jul; 121(3):224-226. PubMed ID: 28529009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exome sequencing identifies ACAD9 mutations as a cause of complex I deficiency.
    Haack TB; Danhauser K; Haberberger B; Hoser J; Strecker V; Boehm D; Uziel G; Lamantea E; Invernizzi F; Poulton J; Rolinski B; Iuso A; Biskup S; Schmidt T; Mewes HW; Wittig I; Meitinger T; Zeviani M; Prokisch H
    Nat Genet; 2010 Dec; 42(12):1131-4. PubMed ID: 21057504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Riboflavin-responsive oxidative phosphorylation complex I deficiency caused by defective ACAD9: new function for an old gene.
    Gerards M; van den Bosch BJ; Danhauser K; Serre V; van Weeghel M; Wanders RJ; Nicolaes GA; Sluiter W; Schoonderwoerd K; Scholte HR; Prokisch H; Rötig A; de Coo IF; Smeets HJ
    Brain; 2011 Jan; 134(Pt 1):210-9. PubMed ID: 20929961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of a wide spectrum of cardiac involvement due to ACAD9 mutations: Report on nine patients.
    Dewulf JP; Barrea C; Vincent MF; De Laet C; Van Coster R; Seneca S; Marie S; Nassogne MC
    Mol Genet Metab; 2016 Jul; 118(3):185-189. PubMed ID: 27233227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High incidence and variable clinical outcome of cardiac hypertrophy due to ACAD9 mutations in childhood.
    Collet M; Assouline Z; Bonnet D; Rio M; Iserin F; Sidi D; Goldenberg A; Lardennois C; Metodiev MD; Haberberger B; Haack T; Munnich A; Prokisch H; Rötig A
    Eur J Hum Genet; 2016 Aug; 24(8):1112-6. PubMed ID: 26669660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An atypical presentation of ACAD9 deficiency: Diagnosis by whole exome sequencing broadens the phenotypic spectrum and alters treatment approach.
    Aintablian HK; Narayanan V; Belnap N; Ramsey K; Grebe TA
    Mol Genet Metab Rep; 2017 Mar; 10():38-44. PubMed ID: 28070495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic simulations on the mitochondrial fatty acid beta-oxidation network.
    Modre-Osprian R; Osprian I; Tilg B; Schreier G; Weinberger KM; Graber A
    BMC Syst Biol; 2009 Jan; 3():2. PubMed ID: 19126203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optic neuropathy linked to ACAD9 pathogenic variants: A potentially riboflavin-responsive disorder?
    Gueguen N; Piarroux J; Sarzi E; Benkirane M; Manes G; Delettre C; Amedro P; Leboucq N; Koenig M; Meyer P; Meunier I; Reynier P; Lenaers G; Roubertie A
    Mitochondrion; 2021 Jul; 59():169-174. PubMed ID: 34023438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation analysis in mitochondrial fatty acid oxidation defects: Exemplified by acyl-CoA dehydrogenase deficiencies, with special focus on genotype-phenotype relationship.
    Gregersen N; Andresen BS; Corydon MJ; Corydon TJ; Olsen RK; Bolund L; Bross P
    Hum Mutat; 2001 Sep; 18(3):169-89. PubMed ID: 11524729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial fatty acid oxidation defects--remaining challenges.
    Gregersen N; Andresen BS; Pedersen CB; Olsen RK; Corydon TJ; Bross P
    J Inherit Metab Dis; 2008 Oct; 31(5):643-57. PubMed ID: 18836889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel mitochondrial complex I assembly factor ACDH-12 in Caenorhabditis elegans.
    Chuaijit S; Boonyatistan W; Boonchuay P; Metheetrairut C; Suthammarak W
    Mitochondrion; 2019 May; 46():91-96. PubMed ID: 29540318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.